Article Details

Buy Rating Affirmed for Matinas BioPharma on Strong Financials and Promising Oral ...

Retrieved on: 2024-05-11 20:26:18

Tags for this article:

Click the tags to see associated articles and topics

Buy Rating Affirmed for Matinas BioPharma on Strong Financials and Promising Oral .... View article details on hiswai:

Excerpt

Jason McCarthy, an analyst from Maxim Group, maintained the Buy rating on Matinas BioPharma (MTNB – Research Report). The associated price...

Article found on: markets.businessinsider.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up